Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Some unresolved issues with botulinum toxin.

B M Guyer1

  • 1DuoMed Limited, Medical Affairs Consultancy, 63 Moberly Road, Salisbury, Wilts, SP1 3BX, UK. bguyer@duomed.co.uk

Journal of Neurology
|May 19, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recommendations for the use of botulinum toxin type A in the management of cerebral palsy.

Gait & posture·2000
Same author

A short exercise and living course for asthmatics.

British journal of diseases of the chest·1988
Same author

Salicylic acid gel for scalp psoriasis.

Clinical and experimental dermatology·1986
Same author

Clinical manifestations of allergy related to breast- and cow's milk-feeding.

Pediatrics·1985
Same author

Recurrent croup.

Archives of disease in childhood·1985
Same author

Cows milk intolerance in Isle of Wight infants.

The British journal of clinical practice·1983
Same journal

The dual role of mTOR in multiple sclerosis pathophysiology: a systematic review.

Journal of neurology·2026
Same journal

Brain-first versus body-first Parkinson's disease: Differential findings on pupillary, brainstem and vagus sonography.

Journal of neurology·2026
Same journal

Spontaneous intracranial hypotension due to pelvic cerebrospinal fluid leak.

Journal of neurology·2026
Same journal

Morbidity and medication use preceding a diagnosis of late-onset Alzheimer's disease: a Danish nationwide study.

Journal of neurology·2026
Same journal

Comorbid autoimmune disease in stiff-person syndrome spectrum disorder: a systematic review and meta-analysis.

Journal of neurology·2026
Same journal

Tetrahydrocannabinol/cannabidiol in the treatment of restless legs syndrome.

Journal of neurology·2026
See all related articles

Botulinum toxin research faces challenges in assay standardization and understanding optimal concentrations. Further investigation is needed to explore potential new mechanisms of action beyond antibody formation.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Botulinum toxin (BoNT) applications are expanding, yet fundamental issues remain unresolved.
  • Current understanding of BoNT activity, standardization, and clinical response is limited.
  • Existing assay nomenclature and unit standardization attempts are inadequate and potentially harmful.

Purpose of the Study:

  • To highlight critical unresolved issues in botulinum toxin research and clinical application.
  • To question the validity of current standardization efforts for botulinum toxin assays.
  • To explore potential novel mechanisms of action for botulinum toxin in new therapeutic contexts.

Main Methods:

  • Literature review and critical analysis of existing botulinum toxin research.

Related Experiment Videos

  • Evaluation of current assay methodologies and nomenclature.
  • Discussion of clinical observations regarding treatment response and loss of efficacy.

    • Main Results:

    • Significant discrepancies exist in botulinum toxin assay nomenclature and units.
    • Optimal therapeutic concentrations for many indications remain undetermined.
    • Loss of response is often prematurely attributed to antibody formation, overlooking other factors.

    Conclusions:

    • There is a critical need for standardized, reliable botulinum toxin assays.
    • Further research is essential to determine optimal dosing and elucidate all mechanisms of action.
    • The clinical utility of botulinum toxin may be underestimated due to a lack of comprehensive understanding.